Variable | Before treatment (n = 50) | After treatment (n = 50) | p value |
---|---|---|---|
QTc, ms | 415.84 ± 24.40 | 410.96 ± 29.41 | 0.48 |
LVEDD, mm | 48.14 ± 2.81 | 49.3 ± 2.33 | 0.26 |
LVESD, mm | 29.8 ± 2.44 | 30.18 ± 2.04 | 0.701 |
LVEDV, ml | 94.96 ± 18.67 | 96.84 ± 17.71 | 0.183 |
LVESV, ml | 31.16 ± 6.51 | 31.92 ± 5.32 | 0.359 |
LVEDVI, ml/m2 | 52.98 ± 9.08 | 54.14 ± 9.59 | 0.133 |
LVESVI, ml/m2 | 17.4 ± 3.01 | 17.82 ± 2.8 | 0.354 |
LVEF, % | 66.04 ± 2.98 | 65.42 ± 4.9 | 0.41 |
LAVI, ml/m2 | 25.96 ± 3.96 | 26.86 ± 4.12 | 0.032 |
Trans-mitral E/A ratio | 1.09 ± 0.38 | 1.1 ± 0.36 | 0.678 |
DT, ms | 182.36 ± 30.85 | 180.98 ± 21.85 | 0.751 |
Lateral mitral E’, cm/s | 14.38 ± 3.59 | 13.62 ± 3.21 | 0.02 |
E/E’ ratio | 6.77 ± 2.44 | 6.61 ± 2.22 | 0.62 |
RVSP, mmHg | 26.34 ± 6.06 | 27.54 ± 7.15 | 0.131 |
Mean PAP, mmHg | 16 ± 3.1 | 16.86 ± 3.47 | 0.097 |
TAPSE, mm | 24.56 ± 3.08 | 23.94 ± 2.8 | 0.164 |
RVFAC, % | 45.72 ± 4.88 | 44.98 ± 4.86 | 0.149 |
LV GLS | −20 (−26 – −16.5) | − 20 (−24 – − 16) | 0.198 |
RV GLS | −22 (−30 – −17) | −21 (− 30 – − 16) | 0.122 |